Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial

References

• AlpertMAMukerjiVVillarrealDEfficacy of betaxolol in the treatment of stable exertional angina pectoris: a dose-ranging studyAngiology199041365762162638
   PubMed Web of Science ®Google Scholar
• AmelingEHde KorteDFMan in 't VeldAImpact of diagnosis and treatment of hypertension on quality of life: a double-blind, randomized, placebo-controlled, cross-over study of betaxololJ Cardiovasc Pharmacol199118752601723773
   PubMed Web of Science ®Google Scholar
• BairdMGBentley-TaylorMMCarruthersSGA study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study GroupClin Invest Med19847951026380858
   PubMed Web of Science ®Google Scholar
• BorchardUPharmacological properties of beta-adrenoreceptor blocking drugsJ Clin Bas Cardiol1998159
   Google Scholar
• BrunJPatient compliance with once-daily and twice-daily oral formulations of 5-izosorbide mononitrate: a comparative studyJ Int Med Res199422266727867871
   PubMed Web of Science ®Google Scholar
• ChrysantSGBittarNBetaxolol in the treatment of stable angina pectorisCardiology199484316218187119
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the association between dose regimens and medication complianceClin Ther200123129631011558866
   PubMed Web of Science ®Google Scholar
• CramerJAEffect of partial compliance on cardiovascular medication effectivenessHeart200288203612117861
   PubMed Web of Science ®Google Scholar
• DetryJMBlockPDe BackerGPatient compliance and therapeutic coverage: amlodipine versus nifedipine (slow-release) in the treatment of angina pectoris. Belgian Collaborative GroupJ Int Med Res199422278867867873
   PubMed Web of Science ®Google Scholar
• ErnePSaxenhoferHWaeberBTime of drug intake in hypertension and angina pectoris. A controlled monitoring studySchweiz Rundsch Med Prax1994831079837939074
   PubMedGoogle Scholar
• FavreODelacretazEBadanMRelationship between the pre-scriber‘s instructions and compliance with antibiotherapy in outpatients treated for an acute infectious diseaseJ Clin Pharmacol199737758
   Web of Science ®Google Scholar
• FigullaHRKrzeminska-PakulaMWrabecKBetaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III Results of a randomized multicenter trial (BETACAR Trial)Int J Cardiol2005doi10.1016/j.ijcard.2005.06.067
   Web of Science ®Google Scholar
• FowlerMBBeta-blockers in heart failure. Do they improve the quality as well as the quantity of life?Eur Heart J199819Suppl PP17259886708
   PubMedGoogle Scholar
• GuillausseauPJObservance et optimisation du traitement antidiabétique oral: étude longitudinalePress Med20043315660
   PubMedGoogle Scholar
• HanedaTIdoAFujikaneTEffect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertensionNippon Ronen Igakkai Zasshi1998353389564739
   PubMedGoogle Scholar
• HaynesRBMcDonaldHPGargAXHelping patients follow prescribed treatment. Clinical applicationsJAMA20022882880312472330
   PubMed Web of Science ®Google Scholar
• HopeCJWuJTuWAssociation of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failureAm J Health Sys Pharm20046120439
   PubMed Web of Science ®Google Scholar
• HorwitzRIViscoliCMBerkmanLTreatment adherence and risk of death after a myocardial infarctionLancet199033654251975045
   PubMed Web of Science ®Google Scholar
• HughesADBagustAHaycoxAThe impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literatureHealth Econ2001106011511747044
   PubMed Web of Science ®Google Scholar
• JohnsonBFWheltonAA study design for comparing the effects of missing daily doses of antihypertensive rugsAm J Therapeutics199412607
   PubMedGoogle Scholar
• KardasPComparison of once daily versus twice daily oral nitrates in stable angina pectorisAm J Cardiol200494213615246905
   PubMed Web of Science ®Google Scholar
• KardasPThe DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes)Diabetes Obes Metab20057722816219016
   PubMed Web of Science ®Google Scholar
• MalhotraSKaranRSPandhiPDrug related medical emergencies in the elderly: role of adverse drug reactions and non-compliancePostgrad Med J200177703711677279
   PubMed Web of Science ®Google Scholar
• McLenachanJMFindlayINWilsonJTTwenty-four-hour beta-blockade in stable angina pectoris: a study of atenolol and betaxololJ Cardiovasc Pharmacol19922031151381024
   PubMed Web of Science ®Google Scholar
• NaraharaKADouble-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators GroupAm J Cardiol199065577822178381
   PubMed Web of Science ®Google Scholar
• NewbyLKLaPointeNMChenAYLong-term adherence to evidence-based secondary prevention theraopies in coronary artery diseaseCirculation20061132031216401776
   PubMed Web of Science ®Google Scholar
• PsatyBMKoepsellTDWagnerEHThe relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockersJAMA1990263165371968518
   PubMed Web of Science ®Google Scholar
• RabinRde CharroFEQ-5D: a measure of health status from the EuroQol GroupAnn Med2001333374311491192
   PubMed Web of Science ®Google Scholar
• ReddyPDunnABThe effect of beta-blockers on health-related qualityof life in patients with heart failurePharmacotherapy2000206798910853624
   PubMed Web of Science ®Google Scholar
• RosnerBFundamentals of biostatistics20005th EditionPacifi c Grove, CADuxbury Press
   Google Scholar
• RoterDLHallJAMeriscaREffectiveness of interventions to improve patient compliance. A meta-analysisMed Care1998361138619708588
   PubMed Web of Science ®Google Scholar
• RuddPAhmedSZacharyVCompliance with medication timing: implication from a medication trial for drug development and clinical practiceJ Clin Res Pharmacoepidemiol199261527
   Google Scholar
• StoneAAShiffmanSSchwartzJEPatient noncompliance with paper diariesBMJ20023241193412016186
   PubMed Web of Science ®Google Scholar
• SullivanSDKrelingDHNoncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimateJ Res Pharm Econ199021933
   Google Scholar
• VrijensBUrquhartJPatient adherence to prescribed antimicrobial drug dosing regimensJ Antimicrob Chemother2005556162715772145
   PubMed Web of Science ®Google Scholar
• WeiLFlynnRMurrayGDUse and adherence to beta-blockers for secondary prevetion of myocardial infarction: who is not getting the treatment?Pharmacoepidemiol Drug Saf199413761615386713
   PubMedGoogle Scholar
• WinklerATeuscherAUMuellerBMonitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureasSwiss Med Wkly20021323798512428192
   PubMed Web of Science ®Google Scholar